D. Cemerlic

  • Citations Per Year
Learn More
The feasibility of combining the Lym-1 monoclonal antibody (MoAb) with interferon-gamma (IFN-gamma) in the treatment of chronic lymphocytic leukemia (CLL) was evaluated. We used an in vitro tumor lysis model that incorporated fresh CLL cells from 21 different patients as targets for two distinct normal human leukocyte effector subsets, neutrophils, and(More)
Lym-1 is a therapeutically promising IgG2a monoclonal antibody (MoAb) that reacts with variant class II molecules expressed on B-lineage malignancies. To optimize antitumor immunotherapy with Lym-1, we determined whether granulocytes could participate in tumor lysis mediated by Lym-1 and whether recombinant interferon gamma (IFN-gamma) could influence this(More)
We studied the morphology and histology of intramural vessels in the sino-atrial [S-A] segment of the cardiac conducting system because of the clinical relevance of the anatomy of the microvascular system for those performing cardiac surgery or coronary angiography, cathetherization or arterialization. In 25 human and 25 canine hearts the vasculature was(More)
  • 1